Melanoma Thickness and Survival Trends in the United States, 1989-2009

Journal of the National Cancer Institute

Volumn 108, Issue 1, 2016, Pages

  Shaikh, Waqas R ^a   Dusza, Stephen W ^b   Weinstock, Martin A ^c,d,e   Oliveria, Susan A ^b   Geller, Alan C ^f   Halpern, Allan C ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

^e BROWN UNIVERSITY   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER SIZE; CANCER SURVIVAL; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MELANOMA; MELANOMA THICKNESS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; THICKNESS; TREND STUDY; UNITED STATES; ADULT; AGE; AGE DISTRIBUTION; AGED; CANCER REGISTRY; EPIDEMIOLOGY; INCIDENCE; MIDDLE AGED; MORTALITY; ODDS RATIO; PATHOLOGY; SKIN TUMOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; ODDS RATIO; SEER PROGRAM; SKIN NEOPLASMS; SURVIVAL RATE; UNITED STATES;

EID: 84961239594     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv294     Document Type: Review

References (25)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30.
2. Howlader NNA, Krapcho M, Garshell J, et al. SEER Cancer Statistics Review, 1975-2010. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
3. Linos E, Swetter SM, Cockburn MG, et al. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009;129(7):1666-1674.
4. Criscione VD, Weinstock MA. Melanoma thickness trends in the United States, 1988-2006. J Invest Dermatol. 2010;130(3):793-797.
5. Jemal A, Saraiya M, Patel P, et al. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol. 2011;65(5 Suppl 1):S17-S25, e1-e3.
6. Pollack LA, Li J, Berkowitz Z, et al. Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol. 2011;65(5 Suppl 1):S78-S86.
7. Shaikh WR, Weinstock MA, Halpern AC, et al. The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008. Cancer Epidemiol. 2013;37(1):64-70.
8. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-351.
9. Dennis LK. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol. 1999;135(3):275-280.
10. Jemal A, Devesa SS, Hartge P, et al. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93(9):678-683.
11. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199-6206.
12. Harlan LC, Lynch CF, Ballard-Barbash R, et al. Trends in the treatment and survival for local and regional cutaneous melanoma in a US populationbased study. Melanoma Res. 2011;21(6):547-554.
13. Marsden JR, Newton-Bishop JA, Burrows L, et al. Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol. 2010;163(2):238-256.
14. Lee C, Collichio F, Ollila D, et al. Historical review of melanoma treatment and outcomes. Clin Dermatol. 2013;31(2):141-147.
15. Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer JAMA. 2000;283(22):2975-2978.
16. Rouhani P, Hu S, Kirsner RS. Melanoma in Hispanic and black Americans. Cancer Control. 2008;15(3):248-253.
17. Zell JA, Cinar P, Mobasher M, et al. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008;26(1):66-75.
18. Wu XC, Eide MJ, King J, et al. Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006. J Am Acad Dermatol. 2011;65(5 Suppl 1):S26-S37.
19. Reyes Ortiz CA, Freeman JL, Kuo YF, et al. The influence of marital status on stage at diagnosis and survival of older persons with melanoma. J Gerontol A Biol Sci Med Sci. 2007;62(8):892-898.
20. McLaughlin JM, Fisher JL, Paskett ED. Marital status and stage at diagnosis of cutaneous melanoma: results from the Surveillance Epidemiology and End Results (SEER) program, 1973-2006. Cancer. 2011;117(9):1984-1993.
21. Demierre MF, Chung C, Miller DR, et al. Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol. 2005;141(6):745-750.
22. Baumert J, Erazo N, Ruf E, et al. Time trends in suicide mortality vary in choice of methods: an analysis of 145,865 fatal suicide cases in Germany 1991-2002. Soc Psychiatry Psychiatr Epidemiol. 2008;43(11):913-919.
23. Bradford PT, Goldstein AM, McMaster ML, et al. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol. 2009;145(4):427-434.
24. Shaikh WR, Xiong M, Weinstock MA. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007. Arch Dermatol. 2012;148(1):30-36.
25. Scolyer RA, Long GV, Thompson JF. Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Mol Oncol. 2011;5(2):124-136.